CVE-2020-14492

CVE-2020-14492 is a medium-severity vulnerability in Openclinic Ga Project Openclinic Ga with a CVSS 3.x base score of 5.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

OpenClinic GA 5.09.02 and 5.89.05b does not properly neutralize user-controllable input, which may allow the execution of malicious code within the user’s browser.

Frequently asked questions

What is CVE-2020-14492?
OpenClinic GA 5.09.02 and 5.89.05b does not properly neutralize user-controllable input, which may allow the execution of malicious code within the user’s browser.
How severe is CVE-2020-14492?
CVE-2020-14492 has a CVSS 3.x base score of 5.4, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2020-14492 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (65th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-14492?
CVE-2020-14492 primarily affects Openclinic Ga Project Openclinic Ga. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2020-14492?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2020-14492 published?
CVE-2020-14492 was published on 2020-07-29 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Openclinic Ga Project Openclinic Ga

All CVEs affecting Openclinic Ga Project Openclinic Ga →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →